NASDAQ · HYFT
Healthcare · Biotechnology
$1.10
Down-$0.05 (-4.09%)
Updated Nov 4, 2026, 8:24 PM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · HYFT
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
HYFT closed at $1.10 after 21 trading sessions, down 29.03% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $1.10 | $1.1688 | $1.07 | $1.10 | 195.31K |
| Nov 2, 2026 | $1.16 | $1.18 | $1.0703 | $1.10 | 149.25K |
| Oct 30, 2026 | $1.16 | $1.21 | $1.10 | $1.13 | 195.33K |
| Oct 29, 2026 | $1.21 | $1.2699 | $1.18 | $1.20 | 88.65K |
| Oct 28, 2026 | $1.16 | $1.23 | $1.15 | $1.18 | 112.41K |
| Oct 27, 2026 | $1.15 | $1.17 | $1.14 | $1.16 | 78.64K |
| Oct 26, 2026 | $1.16 | $1.21 | $1.10 | $1.15 | 157.14K |
| Oct 23, 2026 | $1.21 | $1.21 | $1.1114 | $1.16 | 285.51K |
| Oct 22, 2026 | $1.27 | $1.30 | $1.15 | $1.20 | 215.66K |
| Oct 21, 2026 | $1.34 | $1.3648 | $1.2601 | $1.27 | 114.26K |
| Oct 20, 2026 | $1.34 | $1.39 | $1.27 | $1.29 | 241.98K |
| Oct 19, 2026 | $1.34 | $1.35 | $1.31 | $1.32 | 137.5K |
| Oct 16, 2026 | $1.39 | $1.4191 | $1.30 | $1.31 | 244.19K |
| Oct 15, 2026 | $1.38 | $1.41 | $1.34 | $1.40 | 140.9K |
| Oct 14, 2026 | $1.46 | $1.4699 | $1.35 | $1.37 | 292.31K |
| Oct 13, 2026 | $1.43 | $1.50 | $1.38 | $1.48 | 576.03K |
| Oct 12, 2026 | $1.50 | $1.52 | $1.395 | $1.40 | 198.69K |
| Oct 9, 2026 | $1.44 | $1.5361 | $1.42 | $1.495 | 238.91K |
| Oct 8, 2026 | $1.50 | $1.5066 | $1.395 | $1.43 | 402.44K |
| Oct 7, 2026 | $1.52 | $1.53 | $1.45 | $1.50 | 322.13K |
| Oct 6, 2026 | $1.56 | $1.80 | $1.47 | $1.55 | 1.89M |
The latest Smart Investors Daily articles mentioning HYFT.
Company
Market Activity
Research & News
HYFT research
Company profile and research snapshot.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 19, 2026 | HC Wainwright & Co. | Buy | — |
| Apr 16, 2026 | Jones Trading | Buy | — |
No generated briefing is available yet.
Yahoo · Oct 22, 2026
AUSTIN, Texas, October 22, 2026--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced that Thomas Lynch, PhD, has departed the company and ceased to serve as Chief Business Officer, effective October 16, 2026.
Yahoo · Oct 21, 2026
AUSTIN, Texas, October 21, 2026--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today published a white paper showing that its LensAI™ immunogenicity screening ran across an entire public antibody database of 890,634 sequences in 4 hours and 41 minutes on Amazon EC2 Hpc8a instances powered by 5th Gen AMD EPYC™ processors, delivering up to 43% lower cost per sequence than a comparable Intel configuration running identical code.
Yahoo · Oct 14, 2026
BOSTON, October 14, 2026--MindWalk Holdings Corp. (NASDAQ: HYFT) ("MindWalk" or the "Company"), a Bio-Native AI company, today announced three senior appointments that strengthen its Boston-based development leadership as the Company’s pipeline advances toward preclinical efficacy studies. Zachary Maben, PhD, joins as Director, Antigen Discovery & Protein Engineering, from Arbor Biotechnologies and previously Pfizer. Joanne Lim, PhD, joins as Director, Preclinical Development, from Orum Therapeu
Yahoo · Oct 6, 2026
AUSTIN, Texas, October 06, 2026--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today outlined why the ontology layer now being built across enterprise AI does not reach biological function, and why life sciences requires a biological context layer of its own. ReefIQ™, MindWalk's biological context layer for life sciences, supplies what a horizontal ontology cannot: a governed, model-agnostic representation of what biology does, available from the first day of a de
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning HYFT.
